Chartwell Investment Partners, LLC Novavax Inc Transaction History

Chartwell Investment Partners, LLC

  • $2.91 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 19, 2021
SELL
$121.0 - $257.67 $1.31 Million - $2.79 Million
-10,813 Closed
0 $0
Q1 2021

May 03, 2021
BUY
$112.98 - $319.93 $989,591 - $2.8 Million
8,759 Added 426.44%
10,813 $1.96 Million
Q4 2020

Feb 09, 2021
SELL
$78.74 - $139.5 $37,007 - $65,565
-470 Reduced 18.62%
2,054 $229,000
Q3 2020

Nov 16, 2020
BUY
$79.44 - $178.51 $200,506 - $450,559
2,524 New
2,524 $273,000

Others Institutions Holding NVAX

# of Institutions
285
Shares Held
93.8M
Call Options Held
5.4M
Put Options Held
8.76M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $617M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email